Sign in
4

Changes in Ownership

Eledon Pharmaceuticals, Inc. Filed Acc 0000899243-17-012934

Chief Development Officer bought 11,111 shares at $9.99 ($110,999)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
TURKEL CATHERINE C. Chief Development Officer 2017-05-10 Purchase +11,111 $9.99 $110,999 24,519 D
Open-market purchases · 11,111 sh · avg $9.99 · $110,999
Loading xslF345X03/doc4.xml…